FI881122A0 - Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista - Google Patents

Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista

Info

Publication number
FI881122A0
FI881122A0 FI881122A FI881122A FI881122A0 FI 881122 A0 FI881122 A0 FI 881122A0 FI 881122 A FI881122 A FI 881122A FI 881122 A FI881122 A FI 881122A FI 881122 A0 FI881122 A0 FI 881122A0
Authority
FI
Finland
Prior art keywords
proteins
human
isolating
procedure
animal tissue
Prior art date
Application number
FI881122A
Other languages
English (en)
Swedish (sv)
Other versions
FI881122A (fi
FI99114C (fi
FI99114B (fi
Inventor
Dietrich Brocks
Rupert Timpl
Mats Paulsson
Original Assignee
Hoechst Ag
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag, Max Planck Gesellschaft filed Critical Hoechst Ag
Publication of FI881122A0 publication Critical patent/FI881122A0/fi
Publication of FI881122A publication Critical patent/FI881122A/fi
Application granted granted Critical
Publication of FI99114B publication Critical patent/FI99114B/fi
Publication of FI99114C publication Critical patent/FI99114C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S261/00—Gas and liquid contact apparatus
    • Y10S261/88—Aroma dispensers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/82—Subcellular parts of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
  • Tires In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI881122A 1987-03-13 1988-03-10 Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista FI99114C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873708198 DE3708198A1 (de) 1987-03-13 1987-03-13 Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
DE3708198 1987-03-13

Publications (4)

Publication Number Publication Date
FI881122A0 true FI881122A0 (fi) 1988-03-10
FI881122A FI881122A (fi) 1988-09-14
FI99114B FI99114B (fi) 1997-06-30
FI99114C FI99114C (fi) 1997-10-10

Family

ID=6323001

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881122A FI99114C (fi) 1987-03-13 1988-03-10 Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista

Country Status (11)

Country Link
US (1) US5147782A (fi)
EP (1) EP0282018B1 (fi)
JP (1) JP2532559B2 (fi)
AT (1) ATE124706T1 (fi)
DE (2) DE3708198A1 (fi)
DK (1) DK173677B1 (fi)
ES (1) ES2074983T3 (fi)
FI (1) FI99114C (fi)
IE (1) IE67563B1 (fi)
NO (1) NO173336C (fi)
PT (1) PT86944B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512657A (en) * 1988-12-12 1996-04-30 Bainbridge Sciences, Inc. Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
US5541076A (en) * 1988-12-12 1996-07-30 Bard Diagnostic Sciences, Inc. Methods for determining the invasiveness of a bladder tumor
WO1992019970A1 (en) * 1991-04-26 1992-11-12 Emanuel Calenoff Methods to detect and treat diseases caused by bacterial allergens
NZ524868A (en) 2003-03-21 2005-09-30 Velvet Antler Res New Zealand Process for purifying low molecular weight proteins from tissue in situ
NZ526157A (en) * 2003-05-27 2006-01-27 Velvet Antler Res New Zealand Method for the extraction of deer antler and use of the extract therefrom
US20070190165A1 (en) * 2005-10-21 2007-08-16 Brey Eric M Tissue-specific basement membrane gels
US10076535B2 (en) 2012-04-27 2018-09-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing
WO2024130365A1 (en) * 2022-12-21 2024-06-27 Cristália Produtos Químicos Farmacêuticos Ltda Laminin extraction, purification and polymerization processes, use, polylaminin and kit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923583A1 (de) * 1979-06-11 1980-12-18 Max Planck Gesellschaft Verfahren zur immunologischen bestimmung von basalmembranmaterial und hierfuer geeignete neue basalmembranfragmente
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
DE3511199A1 (de) * 1985-03-28 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur immunologischen bestimmung von heparansulfat-proteoglykan, verfahren zur herstellung bzw. reinigung von dafuer geeignetem heparansulfat-proteoglykan aus basalmembran-haltigen geweben
JPH01155757A (ja) * 1987-12-11 1989-06-19 Nec Corp 可変不在転送解除方式

Also Published As

Publication number Publication date
FI881122A (fi) 1988-09-14
DE3854096D1 (de) 1995-08-10
IE880729L (en) 1988-09-13
IE67563B1 (en) 1996-04-17
NO881111D0 (no) 1988-03-11
FI99114C (fi) 1997-10-10
US5147782A (en) 1992-09-15
FI99114B (fi) 1997-06-30
DE3708198A1 (de) 1988-09-22
ATE124706T1 (de) 1995-07-15
NO173336C (no) 1993-12-01
PT86944A (pt) 1988-04-01
NO881111L (no) 1988-09-14
DK173677B1 (da) 2001-06-11
EP0282018A2 (de) 1988-09-14
EP0282018A3 (en) 1990-01-24
PT86944B (pt) 1992-05-29
JPS63243098A (ja) 1988-10-07
DK135688A (da) 1988-09-14
NO173336B (no) 1993-08-23
ES2074983T3 (es) 1995-10-01
DK135688D0 (da) 1988-03-11
EP0282018B1 (de) 1995-07-05
JP2532559B2 (ja) 1996-09-11

Similar Documents

Publication Publication Date Title
EP0089666A3 (en) Human growth hormone variants
NO833769L (no) Immunogent protein- eller peptidkompleks, fremgangsmaate for fremstilling og anvendelse herav som immunstimulerende middel og som vaksine
ES8506087A1 (es) Procedimiento para preparar proteina de uroquinasa humana bioactiva
SG17493G (en) Ozone decontamination of blood and blood products
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
NO904023L (no) Blanding som induserer binding.
ES2110414T3 (es) Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion.
AU524777B2 (en) Isolation of tissue protein ppg.
NL7800027A (nl) Werkwijze voor de bereiding van aan polyamide gefixeerd biologisch actief eiwit.
HU9201552D0 (en) Medical preparation for the neutralization of procoagulant activity cused by tumorous cells
FI99114B (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
SE8100614L (sv) Humant relaxin och sett for framstellning derav
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
GB2003887A (en) Isolation of peptides from urine
FI885025A (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
DK0436712T3 (da) Lim til sammenføjning af humant eller animalsk væv
SE8600987L (sv) Forfarande for framstellning av ett protein- koncentrat ur helblod
NO881942L (no) Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten.
EP0136093A3 (en) Anti-cancer factors
FR2559157B1 (fr) Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
AU7692987A (en) Reagent kit, its use and diagnostic process for the detection of hpasp(human pancreatic specific protein)
GB8906796D0 (en) Method of enhancing neutralising antibody activity in human or animal sera or in other body secretions
ATE81587T1 (de) Medizinisches praeparat zur behandlung von hautleiden.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT

Owner name: MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENS